The U.S. government will begin imposing penalties in 2025 on drug companies that charge its Medicare program prices that rise faster than inflation, the Centers for Medicare & Medicaid Services said on Thursday.
https://www.pharmalive.com/wp-content/uploads/2022/12/Reuterspillpackets.jpg607960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-02-10 05:17:332023-02-10 12:18:59U.S. government to start imposing inflation penalties on drugmakers in 2025
